API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 3 sources · 20 days · First seen · Last updated

Alzchem Group nitroguanidine production expansion

Overview

Alzchem Group is expanding its production capacities to meet high demand for creatine and nitroguanidine. In Germany, the company is investing approximately 120 million euros in Trostberg, with operations expected to begin in the second half of 2027.

To support the US defense industry, the company is also planning a nitroguanidine production facility at its Bushy Park site in the United States. The supervisory board has approved the planning phase and the ordering of long-lead equipment for this project. The estimated investment is approximately 150 million USD, which is to be primarily funded through a non-repayable investment grant from the US Department of Defense, alongside smaller amounts of support from state and county levels.

Entities

China · Trostberg · United States · Alzchem Group · US Department of Defense

Timeline

  1. [BUSINESS] 3 sources
    Alzchem Group AG approves US nitroguanidine plant expansion

    Alzchem Group AG is moving forward with a USD 150 million nitroguanidine production plant in the US, funded largely by a USD 150 million grant from the US Department of Defense.

  2. [BUSINESS] 2 sources
    Alzchem Group expands capacity amid creatine and nitroguanidine demand

    Alzchem Group reports rising revenue and EBITDA, driven by creatine demand and a strategic nitroguanidine expansion in Germany and the USA.

Sources

ad-hoc-news.de · biotech-investments.com · finanznachrichten.de